These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 19540521

  • 1. Liver function as assessed by breath tests in patients with hepatocellular carcinoma.
    Palmieri VO, Grattagliano I, Minerva F, Pollice S, Palasciano G, Portincasa P.
    J Surg Res; 2009 Dec; 157(2):199-207. PubMed ID: 19540521
    [Abstract] [Full Text] [Related]

  • 2. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].
    Wang YB, Chen MH, Yan K, Yang W, Dai Y, Yin SS.
    Ai Zheng; 2005 Jul; 24(7):827-33. PubMed ID: 16004809
    [Abstract] [Full Text] [Related]

  • 3. [Clinical features of liver abscess developed after radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma].
    Kim MH, Choi MS, Choi YS, Kim DY, Lee JM, Paik SW, Lee JH, Koh KC, Yoo BC, Choi D, Rhee JC.
    Korean J Hepatol; 2006 Mar; 12(1):55-64. PubMed ID: 16565606
    [Abstract] [Full Text] [Related]

  • 4. [Radiofrequency ablation with or without transcather arterial chemoembolization for management of hepatocellular carcinoma].
    Li ZR, Kang Z, Qian JS, Zhu KS, Jiang ZB, Huang MS, Guan SH, Shan H.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1749-51. PubMed ID: 18024306
    [Abstract] [Full Text] [Related]

  • 5. Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma.
    Helmberger T, Dogan S, Straub G, Schrader A, Jüngst C, Reiser M, Waggershauser T, Jakobs T, Hoffmann RT, Löhe F, Graeb C, Rau HG, Schauer R, Jauch KW, Caselmann WH, Göke B, Jüngst D.
    Digestion; 2007 Nov; 75(2-3):104-12. PubMed ID: 17598962
    [Abstract] [Full Text] [Related]

  • 6. The effect of transcatheter arterial chemoembolization on CYP1A2 activity in patients with hepatocellular carcinoma.
    Huang W, Qu ZQ, Li XD, He P, Ding N, Zhang SL, Wu MC.
    J Clin Pharm Ther; 2008 Oct; 33(5):489-93. PubMed ID: 18834363
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the 13C-methacetin breath test for quantitative liver function testing.
    Klatt S, Taut C, Mayer D, Adler G, Beckh K.
    Z Gastroenterol; 1997 Aug; 35(8):609-14. PubMed ID: 9297776
    [Abstract] [Full Text] [Related]

  • 8. Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma.
    Marin HL, Furth EE, Olthoff K, Shaked A, Soulen MC.
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):169-76. PubMed ID: 19565046
    [Abstract] [Full Text] [Related]

  • 9. [Cytokine-induced killer cell fusion to lower recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization sequentially combined with radiofrequency ablation: a randomized trial].
    Zhao M, Wu PH, Zeng YX, Xia JC, Zhang FJ, Xian LJ, Zhang YP, Zhou K, Fan WJ, Zhang L, Gao F, Zhou QM.
    Zhonghua Yi Xue Za Zhi; 2006 Jul 11; 86(26):1823-8. PubMed ID: 17054858
    [Abstract] [Full Text] [Related]

  • 10. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
    Kim KM, Kim JH, Park IS, Ko GY, Yoon HK, Sung KB, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.
    J Gastroenterol Hepatol; 2009 May 11; 24(5):806-14. PubMed ID: 19207681
    [Abstract] [Full Text] [Related]

  • 11. Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolization.
    Chok KS, Ng KK, Poon RT, Lam CM, Yuen J, Tso WK, Fan ST.
    Arch Surg; 2006 Dec 11; 141(12):1231-6. PubMed ID: 17178966
    [Abstract] [Full Text] [Related]

  • 12. 13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis.
    Holtmeier J, Leuschner M, Schneider A, Leuschner U, Caspary WF, Braden B.
    Scand J Gastroenterol; 2006 Nov 11; 41(11):1336-41. PubMed ID: 17060128
    [Abstract] [Full Text] [Related]

  • 13. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC.
    Yang P, Liang M, Zhang Y, Shen B.
    Adv Ther; 2008 Aug 11; 25(8):787-94. PubMed ID: 18670743
    [Abstract] [Full Text] [Related]

  • 14. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy.
    Bloomston M, Binitie O, Fraiji E, Murr M, Zervos E, Goldin S, Kudryk B, Zwiebel B, Black T, Fargher S, Rosemurgy AS.
    Am Surg; 2002 Sep 11; 68(9):827-31. PubMed ID: 12356160
    [Abstract] [Full Text] [Related]

  • 15. Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
    Hsu CY, Huang YH, Chiou YY, Su CW, Lin HC, Lee RC, Chiang JH, Huo TI, Lee FY, Lee SD.
    Liver Transpl; 2011 May 11; 17(5):556-66. PubMed ID: 21506244
    [Abstract] [Full Text] [Related]

  • 16. Changes in immunological function after treatment with transarterial chemoembolization plus radiofrequency ablation in hepatocellular carcinoma patients.
    Guan HT, Wang J, Yang M, Song L, Tong XQ, Zou YH.
    Chin Med J (Engl); 2013 May 11; 126(19):3651-5. PubMed ID: 24112158
    [Abstract] [Full Text] [Related]

  • 17. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K, Shiraki K, Yamakado K, Mizuno S, Hori T, Yagi S, Hamada T, Iida T, Nakamura I, Fujii K, Usui M, Isaji S, Ito K, Tagawa S, Takeda K, Yokoi H, Noguchi T.
    J Gastroenterol Hepatol; 2008 Mar 11; 23(3):482-90. PubMed ID: 18086115
    [Abstract] [Full Text] [Related]

  • 18. Radiofrequency ablation and chemoembolization for hepatocellular carcinoma.
    Georgiades CS, Hong K, Geschwind JF.
    Cancer J; 2008 Mar 11; 14(2):117-22. PubMed ID: 18391617
    [Abstract] [Full Text] [Related]

  • 19. [Comparision of different interventional therapies for primary liver cancer].
    Liu YM, Qin H, Wang CB, Fang XH, Ma QY.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar 11; 29(3):232-5. PubMed ID: 17649645
    [Abstract] [Full Text] [Related]

  • 20. A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma.
    Lu W, Li YH, Yu ZJ, He XF, Chen Y, Zhao JB, Zhu ZY.
    Hepatogastroenterology; 2007 Mar 11; 54(77):1499-502. PubMed ID: 17708284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.